The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4)

EDITORIAL  THERAGNOSTICS APPLICATIONS AND CHALLENGESFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):297-8

Theragnostics applications and challenges

Laura EVANGELISTA *, Luigi MANSI

HTML PDF

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):299-305

Theragnostics before we found its name

Sergio MODONI *, Savvas FRANGOS, Ioannis IAKOVOU, Michele BOERO, Luigi MANSI

Abstract HTML PDF

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGESFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):306-14

Theragnostic radionuclides: a clinical perspective

Jacek KOZIOROWSKI *, James BALLINGER

Abstract HTML PDF

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGESFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):315-26

Side effects of theragnostic agents currently employed in clinical practice

Alessio RIZZO *, Salvatore ANNUNZIATA, Massimo SALVATORI

Abstract HTML PDF

SPECIAL ARTICLE  THERAGNOSTICS APPLICATIONS AND CHALLENGES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):327-32

Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization

Francesco CICONE *, Silvano GNESIN, Marta CREMONESI

Abstract HTML PDF

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGESFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):333-41

Theragnostics in prostate cancer

Andrea FAROLFI *, Riccardo MEI, Sakaria ALI, Paolo CASTELLUCCI

Abstract HTML PDF

SPECIAL ARTICLE  THERAGNOSTICS APPLICATIONS AND CHALLENGES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):342-52

Theragnostic in neuroendocrine tumors

Irene MARINI, Maddalena SANSOVINI, Alberto BONGIOVANNI, Silvia NICOLINI, Ilaria GRASSI, Nicoletta RANALLO, Manuela MONTI, Valentina DI IORIO, Luca GERMANÒ, Paola CAROLI, Anna SARNELLI, Giovanni PAGANELLI, Stefano SEVERI *

Abstract HTML PDF

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):353-70

Theragnostics in primary and secondary liver tumors: the need for a personalized approach

Luca FILIPPI *, Arthur J. BRAAT

Abstract HTML PDF

REVIEW  THERAGNOSTICS APPLICATIONS AND CHALLENGES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):371-5

Challenges in theragnostics

Laura EVANGELISTA *, Diego CECCHIN, Jolanta KUNIKOWSKA

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):376-85

Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin’s lymphoma

Naglaa M. KAMAL, Khaled El-SABAN *

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):386-95

Evaluation and clinical quantification of neoplastic lesions and physiological structures in TOF- versus non-TOF-PET/MRI: a pilot study

Felipe de GALIZA BARBOSA *, Gaspar DELSO, Konstantinos G. ZEIMPEKIS, Edwin E. ter VOERT, Martin HÜLLNER, Paul STOLZMANN, Patrick VEIT‑HAIBACH

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):396-401

Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior

Alessandra BACCA, Angela PUCCI, Daniele LORENZINI, Serena CHIACCHIO, Duccio VOLTERRANI, Mauro FERRARI, Stefano SELLARI FRANCESCHINI, Gabriele MATERAZZI, Fulvio BASOLO, Giampaolo BERNINI *

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):402-9

Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria

Naelle LOMBION, Philippe ROBIN, Adrian TEMPESCUL, Pierre-Yves LE ROUX, Ulrike SCHICK, Gaëlle GUILLERM, Jean-Christophe IANOTTO, Christian BERTHOU, Pierre-Yves SALAÜN, Ronan ABGRAL *

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):410-5

Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma

Alberto BIGGI, Fabrizio BERGESIO, Stephane CHAUVIE, Andrea BIANCHI *, Massimo MENGA, Federico FALLANCA, Martin HUTCHINGS, Michele GREGIANIN, Michel MEIGNAN, Andrea GALLAMINI

Abstract HTML PDF